Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-219"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100922.20.3-219"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"The new European regulation on biocides is not only an internal market matter. It is also a matter of health and environmental protection. That, in brief, is the message sent out by the European Parliament today
Of course, several demands from manufacturers have to be met concerning these products for use against vermin, such as access to the European market, time taken for the approval procedures, non-duplication of tests and consistency with legislation on pesticides. That in no way constitutes a blank cheque for manufacturers. The principle of substitution for the most harmful substances is clearly recognised. That mainly concerns persistent, bioaccumulable and toxic substances (PBT) and endocrine disrupters.
It is recognised that responsibility rests with all those involved, including manufacturers who place on the market articles treated with biocides. Let us not forget the toxic sofas affair! I have one regret, however, and that is the rejection of an amendment which stipulated that manufacturers should pay an annual fee, at reduced rates for small and medium-sized enterprises (SME), so as to make it possible for the Chemicals Agency in Stockholm to fulfil its brief. One thing is clear: with limited resources, it will be difficult to carry out reliable tests and so to reduce health risks for users."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples